Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04950309 · ClinicalTrials.gov registry record · NA

Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array

A NA study of Normal Physiology, sponsored by National Institute of Mental Health (NIMH).

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT04950309 is a NA study of Normal Physiology that is actively recruiting participants, run by National Institute of Mental Health (NIMH). The registered enrollment target is 75 participants, below the 1,290-participant average among 25 other Normal Physiology trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04950309, a NA study of Normal Physiology, is actively recruiting participants, sponsored by National Institute of Mental Health (NIMH).

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

Background: Brain activity produces magnetic fields. These fields can be measured outside the head. Existing technology, called MEG, measures these fields. Researchers are testing a new type of magnetic field sensor called OPM. They hope it can help pinpoint with very high accuracy where brain activity is generated. Objective: To develop and test a new type of sensor for measuring the magnetic fields produced by brain activity. Eligibility: Healthy people ages 18-65 who had a magnetic resonance imaging (MRI) scan under protocol 17-M-0181. Design: Participants may be asked to complete sessions on both the traditional MEG instrument and the OPM array. For the MEG, 3 small coils will be placed on the participant s face with tape. Their head will be positioned inside the MEG device. For the OPM, sensors are housed in a 3d printed array. The sensors will be attached to a cap placed on the participant s head. For both scans, participants will be seated in a chair inside a magnetically shielded room. They may complete several tasks. In one task, plastic cells will be placed on their fingers. Puffs of air will be sent to these cells, which will stimulate the sense of touch. Other tasks may include the following stimuli: visual (such as checkerboards), auditory (such as beeps and tones), or language (words and letters). Researchers may also obtain recordings while they stimulate the nerve in the participant s forearm using electrical current in small electrodes. Participation is expected to last for 1 day. Additional optional scans may be offered for up to 1 year....

Conditions Studied

Interventions

  • DEVICE SQUID MEG
  • DEVICE OPM MEG

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2022-05-12
Est. Completion 2026-08-01
Phase NA

What the Registry Record Tells You About NCT04950309

The ClinicalTrials.gov registry entry for NCT04950309 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,290-participant average among 25 other Normal Physiology trials with a reported enrollment target (94% lower). The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Normal Physiology appearing as the primary indexed condition, and to 2 interventions - of which SQUID MEG is the first listed.

NCT04950309 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT04950309 about?

NCT04950309 is a clinical study titled "Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array". Background: Brain activity produces magnetic fields. These fields can be measured outside the head. Existing technology, called MEG, measures these fields. Researchers are testing a new type of magnetic field sensor called OPM. They hope it can help pinpoint with very high accuracy where brain acti...

What is the current status of trial NCT04950309?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2022-05-12. Estimated completion is 2026-08-01.

What conditions does trial NCT04950309 study?

This clinical trial studies the following conditions: Normal Physiology.

What interventions are being tested in trial NCT04950309?

The interventions under investigation include: SQUID MEG (DEVICE), OPM MEG (DEVICE).

Who is sponsoring clinical trial NCT04950309?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04950309 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Normal Physiology

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.